Related Experiment Video
Updated: Jun 6, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
New avenues to target Wnt/β-catenin signaling
Folkert Verkaar1, Guido J R Zaman
1Merck Research Laboratories, MSD, Molecular Pharmacology & DMPK, PO Box 20, 5340 BH Oss, The Netherlands.
Abstract:
Wnt/β-catenin signaling is an evolutionarily conserved signaling cascade with imperative roles during development and in adult stem cell maintenance. Hyperactivation of Wnt/β-catenin drives various cancers, whereas hypoactivation underlies bone malformations and neurodegenerative disorders. Although several small molecule modulators of Wnt/β-catenin signaling have been identified, none have progressed into clinical trials yet. Recent studies employing genomics and proteomics approaches have yielded more druggable targets, such as kinases and seven-transmembrane receptors. In addition, new assay methods enable a more targeted approach for high-throughput screening of this pathway and are expected to deliver clinical candidates in the coming decade.
Insights
The Wnt/β-catenin pathway is crucial for development and stem cells. New targets and screening methods may lead to drugs for cancer and other diseases within a decade.
Area of Science:
- Molecular Biology
- Cell Signaling
- Drug Discovery
Background:
- The Wnt/β-catenin pathway is evolutionarily conserved and vital for development and adult stem cell maintenance.
- Dysregulation of this pathway is implicated in various diseases, including cancers, bone malformations, and neurodegenerative disorders.
Purpose of the Study:
- To review the current landscape of Wnt/β-catenin signaling modulators and identify emerging druggable targets.
- To highlight advancements in assay methods for high-throughput screening of this pathway.
Main Methods:
- Genomics and proteomics approaches to identify novel targets.
- Review of existing small molecule modulators.
- Analysis of new high-throughput screening assay methods.
Main Results:
- Several new druggable targets, including kinases and seven-transmembrane receptors, have been identified through omics studies.
- Despite identified modulators, none have reached clinical trials.
- Advancements in assay technologies are paving the way for more targeted screening.
Conclusions:
- The Wnt/β-catenin pathway presents significant therapeutic potential for various diseases.
- Emerging targets and improved screening methods are expected to yield clinical candidates in the near future.
More Related Videos
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
TGF - β Signaling Pathway
